# The Study of Immunogenicity of Quadrivalent Vaccine Against Human Papilloma Virus (HPV) Types 6, 11, 16, and 18 (HPV-6/11/16/18) in Chronic Kidney Disease (CKD) Patients

> **NCT01298869** · — · UNKNOWN · sponsor: **Chulalongkorn University** · enrollment: 60 (estimated)

## Conditions studied

- Chronic Kidney Disease, Stage IV (Severe)
- Chronic Kidney Disease, Stage V

## Interventions

- **BIOLOGICAL:** HPV-6/11/16/18 vaccine

## Key facts

- **NCT ID:** NCT01298869
- **Lead sponsor:** Chulalongkorn University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-02
- **Primary completion:** 2014-08
- **Final completion:** 2014-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2014-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01298869

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01298869, "The Study of Immunogenicity of Quadrivalent Vaccine Against Human Papilloma Virus (HPV) Types 6, 11, 16, and 18 (HPV-6/11/16/18) in Chronic Kidney Disease (CKD) Patients". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01298869. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*